EUVIMEDEUVIMED entdecken
Crossref

Topiramate, a concealed cause of severe metabolic acidosis

Daniel Lovinger, Ryan Schroeder, Kyle Ludwig, Hariharan Regunath

American Journal of Hospital Medicine · 2017

DOI: 10.24150/ajhm/2017.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hospital Medicine, 2017. Verfasst von Daniel Lovinger und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe metabolic acidosis is common among critically ill patients, and topiramate is a rare cause that may fail recognition. We report a lady with acute encephalopathy who had severe non-anion gap metabolic acidosis that served as the clue leading to suspicion and diagnosis of topiramate toxicity and was confirmed by elevated blood topiramate levels. Additionally, we provide a review of literature on all reported cases of topiramate toxicity. Keywords: Topiramate, metabolic acidosis, migraine, altered mental status, carbonic anhydrase.

Zitieren

APA

Lovinger, D., Schroeder, R., Ludwig, K., & Regunath, H. (2017). Topiramate, a concealed cause of severe metabolic acidosis. American Journal of Hospital Medicine. https://doi.org/10.24150/ajhm/2017.024

Vancouver

Lovinger D, Schroeder R, Ludwig K, Regunath H. Topiramate, a concealed cause of severe metabolic acidosis. American Journal of Hospital Medicine. 2017. doi:10.24150/ajhm/2017.024

BibTeX
@article{Lovinger2017,
  author = {Lovinger, Daniel and Schroeder, Ryan and Ludwig, Kyle and Regunath, Hariharan},
  title = {Topiramate, a concealed cause of severe metabolic acidosis},
  journal = {American Journal of Hospital Medicine},
  year = {2017},
  doi = {10.24150/ajhm/2017.024}
}
Kostenlos starten →